Cited by 4,233Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRadiation Therapy and Dosimetry

The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, Mark E., Chen, Zhuo, Shin, Dong M.·2008·Nature Reviews Drug Discovery

Open this paper in CoChat — free account

Abstract

Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/nrd2614

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Self-citation
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citation
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648
Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129

Flagged first, then by citations

Show all 108 references

2 of the 108 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Kurtzberg, J., Moore, J. O. Scudiery, D. & Franklin, A. A phase II study of polyethylene glycol (PEG) conjugated L-asparaginase in patients with refractory acute leukaemias. Proc. Am. Assoc. Cancer Res. 29, 213 (1988).
Socinski, M. & Ramalingham, S. XYOTAX in NSCLC and other solid tumors. Emerging evidence on biological differences between men and women: is gender-specific therapy warranted? Chemotherapy Foundation web site [online], (2005).
Vasey, P. et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin) first member of a new class of chemotherapeutics agents: drug–polymer conjugates. Clin. Cancer Res. 5, 83–94 (1999).

Sorted by citations

Items 201–300 of 1,023

Polyethylene Glycol Backfilling Mitigates the Negative Impact of the Protein Corona on Nanoparticle Cell Targeting
Dai, Q., Walkey, C., & Chan, W. C. W. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309464 · Cited by 373
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 384
Thermo-responsive polymers: Applications of smart materials in drug delivery and tissue engineering
Sponchioni, M., Palmiero, U. C., & Moscatelli, D. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.04.069 · Cited by 380
Single‐Atom Catalysts in Catalytic Biomedicine
Xiang, H., Feng, W., & Chen, Y. (2020) · Advanced Materials · doi:10.1002/adma.201905994 · Cited by 375
Polymeric micelles: nanocarriers for cancer-targeted drug delivery
Zhang, Y., Huang, Y., & Li, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0113-z · Cited by 367
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A. G., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 380
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Gurunathan, S., Kang, M.-H., Qasim, M., & Kim, J.-H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103264 · Cited by 367
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., & Johnson, J. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502011g · Cited by 365
Review on Micro- and Nanolithography Techniques and their Applications
Pimpin, A., & Srituravanich, W. (2012) · Engineering Journal · doi:10.4186/ej.2012.16.1.37 · Cited by 399
Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
Martins, C., Sousa, F., Araújo, F., & Sarmento, B. F. C. C. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201701035 · Cited by 366
Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release
Chen, W., Zhong, P., Meng, F., Cheng, R., Deng, C., Feijén, J., & Zhong, Z. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.001 · Cited by 363
Nanoparticle Size Effects in Biomedical Applications
Dolai, J., Mandal, K., & Jana, N. R. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00987 · Cited by 396
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
Karmali, P. P., & Simberg, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.554818 · Cited by 360
2D MoS2‐Based Nanomaterials for Therapeutic, Bioimaging, and Biosensing Applications
Yadav, V., Roy, S., Singh, P., Khan, Z., & Jaiswal, A. K. (2018) · Small · doi:10.1002/smll.201803706 · Cited by 361
Forty Years of Clathrin‐coated Vesicles
Robinson, M. S. (2015) · Traffic · doi:10.1111/tra.12335 · Cited by 369
Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
Jin, C., Wang, K., Oppong‐Gyebi, A., & Hu, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49801 · Cited by 363
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Xuan, M., Shao, J., Dai, L., He, Q. Z., & Li, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500129 · Cited by 353
Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology
Liu, J., Yu, M., Zhou, C., & Zheng, J. (2013) · Materials Today · doi:10.1016/j.mattod.2013.11.003 · Cited by 360
Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, Z., Yu, H., Zhang, P., Wang, S., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201604300 · Cited by 351
Multifunctional nanoparticles for brain tumor imaging and therapy
Cheng, Y., Morshed, R. A., Auffinger, B., Tobias, A. L., & Lesniak, M. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.006 · Cited by 359
DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy
Xiao, Z., Ji, C., Shi, J., Pridgen, E. M., Frieder, J., Wu, J., & Farokhzad, O. C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204018 · Cited by 351
Ligand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications
Liang, Y., & Kiick, K. L. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.031 · Cited by 352
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 358
Acoustic Propulsion of Nanorod Motors Inside Living Cells
Wang, W., Li, S., Mair, L. O., Ahmed, S., Huang, T. J., & Mallouk, T. E. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309629 · Cited by 348
Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery
Gao, W., Zhang, Y., Zhang, Q., & Zhang, L. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1583-9 · Cited by 356
Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors
Deshayes, S., Cabral, H., Ishii, T., Miura, Y., Kobayashi, S., Yamashita, T., Matsumoto, A., Miyahara, Y., Nishiyama, N., & Kataoka, K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406406h · Cited by 350
The evolving landscape of drug products containing nanomaterials in the United States
D’Mello, S., Cruz, C. N., Chen, M., Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.67 · Cited by 347
In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles
Chen, F., Hong, H., Zhang, Y., Valdovinos, H. F., Shi, S., Kwon, G. S., Theuer, C. P., Barnhart, T. E., & Cai, W. (2013) · ACS Nano · doi:10.1021/nn403617j · Cited by 346
Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection
Haun, J. B., Devaraj, N. K., Hilderbrand, S. A., Lee, H., & Weissleder, R. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.148 · Cited by 348
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 350
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 343
Layer-by-Layer Nanoparticles with a pH-Sheddable Layer for in Vivo Targeting of Tumor Hypoxia
Poon, Z., Chang, D., Zhao, X., & Hammond, P. T. (2011) · ACS Nano · doi:10.1021/nn200876f · Cited by 343
Nanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J. Y., Fong, P., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers
Ye, M., Han, Y., Tang, J., Piao, Y., Liu, X., Zhou, Z., Gao, J., Rao, J., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201702342 · Cited by 340
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
Rizzo, L. Y., Theek, B., Storm, G., Kiessling, F. M., & Lammers, T. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.020 · Cited by 348
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand‐Brynaert, J., Féron, O., & Véronique Préat, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Developing therapeutic microRNAs for cancer
Bader, A. G., Brown, D., Stoudemire, J., & Lammers, P. (2011) · Gene Therapy · doi:10.1038/gt.2011.79 · Cited by 346
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 340
Nanotechnology for Cancer Therapy Based on Chemotherapy
Zhao, C., Cheng, R., Yang, Z., & Tian, Z. (2018) · Molecules · doi:10.3390/molecules23040826 · Cited by 342
RETRACTED ARTICLE: Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Wang, H., Gao, Z. J., Liu, X., Agarwal, P., Zhao, S., Conroy, D. W., Ji, G., Yu, J., Jaroniec, C. P., Liu, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02915-8 · Cited by 331
Retracted
Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities
Deng, S., Gigliobianco, M. R., Censi, R., & Martino, P. D. (2020) · Nanomaterials · doi:10.3390/nano10050847 · Cited by 331
Tumour-on-a-chip provides an optical window into nanoparticle tissue transport
Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V., & Chan, W. C. W. (2013) · Nature Communications · doi:10.1038/ncomms3718 · Cited by 330
Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles
Cao, Z., & Jiang, S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.001 · Cited by 332
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Graf, N., Bielenberg, D. R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O. C., & Lippard, S. J. (2012) · ACS Nano · doi:10.1021/nn301148e · Cited by 327
Silica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy
Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q.-L., Zhang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202399w · Cited by 331
pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
Karimi, M., Eslami, M., Sahandi‐Zangabad, P., Mirab, F., Farajisafiloo, N., Shafaei, Z., Ghosh, D., Bozorgomid, M., Dashkhaneh, F., & Hamblin, M. R. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1389 · Cited by 327
Multifunctional Mesoporous Silica Nanoparticles for Cancer‐Targeted and Controlled Drug Delivery
Zhang, Q., Liu, F., Nguyen, K. T., Ma, X., Wang, X., Xing, B., & Zhao, Y. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201201316 · Cited by 326
CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy
Zhou, M., Li, J., Su, L., Sood, A. K., Liang, D., & Li, C. (2015) · ACS Nano · doi:10.1021/acsnano.5b02635 · Cited by 326
Exosomes as novel bio-carriers for gene and drug delivery
Jiang, X., & Gao, J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.038 · Cited by 324
Hyaluronic Acid–Based Activatable Nanomaterials for Stimuli‐Responsive Imaging and Therapeutics: Beyond CD44‐Mediated Drug Delivery
Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 320
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Kunjachan, S., Pola, R., Gremse, F., Theek, B., Ehling, J., Moeckel, D., Hermanns‐Sachweh, B., Pechar, M., Ulbrich, K., Hennink, W. E., et al. (2014) · Nano Letters · doi:10.1021/nl404391r · Cited by 317
Synthesis and Biomedical Applications of Multifunctional Nanoparticles
Kim, D., Shin, K., Kwon, S. G., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201802309 · Cited by 328
Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J. P., et al. (2019) · Advanced Science · doi:10.1002/advs.201900172 · Cited by 316
Ph-responsive polymer–drug conjugates: design and progress
Pang, X., Jiang, Y., Xiao, Q., Leung, A. W., Hua, H., & Xu, C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.024 · Cited by 317
Nanomaterials for Cancer Therapy and Imaging
Bae, K. H., Chung, H. J., & Park, T. G. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0051-5 · Cited by 320
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 315
Margination of micro- and nano-particles in blood flow and its effect on drug delivery
Müller, K., Fedosov, D. A., & Gompper, G. (2014) · Scientific Reports · doi:10.1038/srep04871 · Cited by 313
Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8
Alves, I. B. V., da Silva, T. G., Militão, G. C. G., Soares, T. A., Rodrigues, N. M., Rodrigues, M. O., Júnior, N. B. D. C., Freire, R. O., & Alves, S. (2012) · RSC Advances · doi:10.1039/c2ra21087h · Cited by 312
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery
Li, Y., Xiao, K., Luo, J., Xiao, W., Lee, J. S., Gonik, A. M., Kato, J., Dong, T. A., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.050 · Cited by 312
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Huang, B., Abraham, W. D., Zheng, Y., Bustamante-Lopez, S. C., Luo, S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 316
Modular Synthesis of Amphiphilic Janus Glycodendrimers and Their Self-Assembly into Glycodendrimersomes and Other Complex Architectures with Bioactivity to Biomedically Relevant Lectins
Percec, V., Leowanawat, P., Sun, H.-J., Kulikov, O., Nusbaum, C. D., Tran, T. M., Bertin, A., Wilson, D. A., Peterca, M., Zhang, S., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403323y · Cited by 310
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles
Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 316
A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas
Li, Y., He, H., Jia, X., Lü, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 316
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin, S., Nehoff, H. L., & Greish, K. F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.013 · Cited by 313
Nanoparticle characterization techniques
Titus, D., Samuel, E. J. J., & Roopan, S. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102579-6.00012-5 · Cited by 309
Hybrid Multicomponent Hydrogels for Tissue Engineering
Jia, X., & Kiick, K. L. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200800284 · Cited by 308
Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response
Wei, X., Shao, B., He, Z., Ye, T., Luo, M., Sang, Y., Liang, X., Wang, W., Luo, S., Yang, S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.9 · Cited by 309
Liposome-based drug co-delivery systems in cancer cells
Vahed, S. Z., Salehi, R., Davaran, S., & Sharifi, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.073 · Cited by 317
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Fang, R. H., Hu, C. J., Chen, K. N. H., Luk, B. T., Carpenter, C. W., Gao, W., Li, S., Zhang, D., Lu, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr03064d · Cited by 304
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
Zhao, Y., Li, Z., Kabehie, S., Botros, Y. Y., Stoddart, J. F., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105371u · Cited by 304
Nanotechnology applied to overcome tumor drug resistance
Gao, Z., Zhang, L., & Sun, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.051 · Cited by 303
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X., Du, J., Ying, X., Lü, W.-L., Lou, J., & Wei, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 307
Onto better TRAILs for cancer treatment
de Miguel, D., Lemke, J., Anel, A., Walczak, H., & Martínez‐Lostao, L. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.174 · Cited by 308
Hybrid nanomaterials for biomedical applications
Taylor-Pashow, K. M. L., Rocca, J. D., Huxford, R. C., & Lin, W. (2010) · Chemical Communications · doi:10.1039/c002073g · Cited by 306
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298
Transcytosis at the blood–brain barrier
Ayloo, S., & Gu, C. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.12.014 · Cited by 315
Emerging role of exosomes in cancer therapy: progress and challenges
Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297
Self-citation
Nanotherapeutics in the EU: an overview on current state and future directions
Pepić, I., Hafner, A., Lovrić, J., & Lakoš, G. P. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55359 · Cited by 295
Nanomedicine applied to translational oncology: A future perspective on cancer treatment
Bregoli, L., Movia, D., Gavigan-Imedio, J. D., Lysaght, J., Reynolds, J., & Prina‐Mello, A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.08.006 · Cited by 304
Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection
Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K. S., Huang, C.-M., & Zhang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111110e · Cited by 294
Supramolecular “Trojan Horse” for Nuclear Delivery of Dual Anticancer Drugs
Cai, Y., Shen, H., Zhan, J., Lin, M., Dai, L., Ren, C., Shi, Y., Liu, J., Gao, J., & Yang, Z. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12322 · Cited by 294
Targeted liposomal drug delivery: a nanoscience and biophysical perspective
Liu, Y., Bravo, K. M. C., & Liu, J. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00605j · Cited by 303
Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity
Kim, T. H., Jiang, H. H., Youn, Y. S., Park, C. W., Tak, K. K., Lee, S., Kim, H., Jon, S., Chen, X. S., & Lee, K. C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.041 · Cited by 293
Supramolecular Nanodevices: From Design Validation to Theranostic Nanomedicine
Cabral, H., Nishiyama, N., & Kataoka, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200094a · Cited by 296
Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers
Li, Y., Xiao, K., Zhu, W., Deng, W., & Lam, K. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.008 · Cited by 295
Magnetic antimicrobial nanocomposite based on bacterial cellulose and silver nanoparticles
Sureshkumar, M., Siswanto, D. Y., & Lee, C. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm00565g · Cited by 295
Nanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 298
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona
Schöttler, S., Landfester, K., & Mailänder, V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602233 · Cited by 292
Rapid Delivery of Drug Carriers Propelled and Navigated by Catalytic Nanoshuttles
Kagan, D., Laocharoensuk, R., Zimmerman, M., Clawson, C., Balasubramanian, S., Kang, D., Bishop, D. K., Sattayasamitsathit, S., Zhang, L., & Wang, J. (2010) · Small · doi:10.1002/smll.201001257 · Cited by 289
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 291
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 296
Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Mangal, S., Gao, W., Li, T., & Zhou, Q. T. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.34 · Cited by 295
Antimicrobial polymeric nanoparticles
Lam, S. J., Wong, E. H. H., Boyer, C. A., & Qiao, G. G. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.07.007 · Cited by 295
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
Zhong, Y., Zhang, J., Cheng, R., Deng, C., Meng, F., Xie, F., & Zhong, Z. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.012 · Cited by 285
Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment
Schladt, T. D., Schneider, K., Schild, H., & Tremel, W. (2011) · Dalton Transactions · doi:10.1039/c0dt00689k · Cited by 295
Sheddable Ternary Nanoparticles for Tumor Acidity-Targeted siRNA Delivery
Yang, X., Du, J., Dou, S., Mao, C., Long, H., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn204240b · Cited by 283
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D.-Y., Nam, E. J., Mora, E., Stone, R. L., Lü, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 281

Authors: Davis, M. E., Chen, Z., & Shin, D. M.
Affiliations: California Institute of Technology (US)
Emory University (US)
Corresponding author: Davis, Mark E.
ORCID: Davis, Mark E.
Chen, Zhuo
Shin, Dong M.
Venue: Nature Reviews Drug Discovery
Publisher: Springer Science and Business Media LLC
Published: 2008-09
Volume: 7
Issue: 9
Pages: 771-782
ISSN: 1474-1776 (ISSN-L)
1474-1784
DOI: 10.1038/nrd2614
OpenAlex: W2082511916
Cited by: 4,233
References: 108
Citations by year: 2026: 68 · 2025: 134 · 2024: 165 · 2023: 143 · 2022: 171 · 2021: 217 · 2020: 224 · 2019: 260 · 2018: 316 · 2017: 340 · 2016: 364 · 2015: 383 · 2014: 385 · 2013: 332 · 2012: 268
FWCI: 7.10
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Drug Discovery (publishedVersion)
PubMed (publishedVersion)
CaltechAUTHORS (California Institute of Technology) (submittedVersion)
Funders: National Cancer Institute (U54CA119338)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Keywords: nanotherapeutics, cancer therapy, nanomedicine, targeted drug delivery, tumor localization, cellular uptake, clinical translation, clinical trials, anticancer agents, adverse drug reactions
MeSH terms: Animals, Antineoplastic Agents, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticle therapeutics: an emerging treatment modality for cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks